Jolanta Bondaruk
The University of Texas MD Anderson Cancer Center(US)
Publications by Year
Research Areas
Bladder and Urothelial Cancer Treatments, Epigenetics and DNA Methylation, Cancer Genomics and Diagnostics, Urinary and Genital Oncology Studies, Ferroptosis and cancer prognosis
Most-Cited Works
- → Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy(2014)1,717 cited
- → Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53(2003)581 cited
- → Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use(2016)337 cited
- → Frequent truncating mutations of STAG2 in bladder cancer(2013)223 cited
- → Detection of Bladder Cancer Using Novel DNA Methylation Biomarkers in Urine Sediments(2011)167 cited
- → Assessment of Luminal and Basal Phenotypes in Bladder Cancer(2020)166 cited
- → Gene Expression Profile of the Clinically Aggressive Micropapillary Variant of Bladder Cancer(2016)156 cited
- → Dysregulation of EMT Drives the Progression to Clinically Aggressive Sarcomatoid Bladder Cancer(2019)148 cited
- → Distinctive Expression Pattern of ErbB Family Receptors Signifies an Aggressive Variant of Bladder Cancer(2007)94 cited
- → Fibroblast Growth Factor Receptor 3 Is a Rational Therapeutic Target in Bladder Cancer(2013)94 cited